Biography
Dr Maansi Joshi is committed to providing the highest level of care through an innovative and personalised approach. With her clinical haematology and international research experience, she aims to provide the best possible outcome for all her patients.
Dr Maansi Joshi is a clinical haematologist at Icon Cancer Centre Canberra. In 2007 Dr Joshi completed her Bachelor of Medicine, Bachelor of Surgery (MBBS) at Maharashtra University of Health Services (MUHS) in Mumbai, India. She subsequently commenced a research position in Human Proteome Research at Uppsala University in Sweden. In 2018 Dr Joshi completed physician training and clinical and laboratory haematology training at Westmead Hospital, Nepean Hospital and The Canberra Hospital. She is a fellow of the Royal Australasian College of Physicians (FRACP) and Royal College of Pathologists of Australasia (FRCPA).
In 2019 she began an advanced haematology fellowship and research associate position at the Mayo Clinic in Rochester, Minnesota, USA. Her research focused on novel therapeutics and cancer genomics. Dr Joshi is extensively involved in clinical research and has published in several high impact peer reviewed journals. She remains actively involved in training the next generation of medical professionals and has been a tutor for medical students throughout her career.
Her clinical experience covers a wide range of malignant and non-malignant blood disorders including multiple myeloma, amyloidosis, lymphoma, myelodysplasia and myeloproliferative neoplasms.
Publications
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation. M. Joshi, J. Taper, C. Forsyth, P. Rowlings, P. Campbell, P. Crispin, & M. Hertzberg. Leukaemia & Lymphoma, 2019; 12: 1–7.
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation. M. Joshi, J. Cook, K. McCullough et al.Blood Cancer Journal, 2021; 11, 49.
Characteristics of patients with MDS with balanced translocations. M. Joshi et al. British Journal of Haematology, 2020; 190(2): 244-248.
Pregnancy outcomes in myeloproliferative neoplasms: A Mayo Clinic report on 102 pregnancies. N. Gangat, M. Joshi, S. Shah, M. Yogarajah, M.M. Patnaik, A. Pardanani, A.P. Wolanskyj‐Spinner & A. Tefferi. American Journal of Haematology, 2020; 95(5): e114-117.
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients. E. Morsia, K. McCullough, M. Joshi et al. American Journal of Haematology, 2020; 95(12): 1151-1521.